ATE423974T1 - Verfahren zum nachweis geringer konzentrationen eines fusionsproteins - Google Patents

Verfahren zum nachweis geringer konzentrationen eines fusionsproteins

Info

Publication number
ATE423974T1
ATE423974T1 AT04774869T AT04774869T ATE423974T1 AT E423974 T1 ATE423974 T1 AT E423974T1 AT 04774869 T AT04774869 T AT 04774869T AT 04774869 T AT04774869 T AT 04774869T AT E423974 T1 ATE423974 T1 AT E423974T1
Authority
AT
Austria
Prior art keywords
fusion protein
sample
protein
binding molecule
low concentrations
Prior art date
Application number
AT04774869T
Other languages
English (en)
Inventor
Frank Staal
Dongen Jacobus Van
Original Assignee
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus Medical Ct filed Critical Univ Erasmus Medical Ct
Application granted granted Critical
Publication of ATE423974T1 publication Critical patent/ATE423974T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04774869T 2003-08-12 2004-08-11 Verfahren zum nachweis geringer konzentrationen eines fusionsproteins ATE423974T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03077529A EP1507147A1 (de) 2003-08-12 2003-08-12 Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein

Publications (1)

Publication Number Publication Date
ATE423974T1 true ATE423974T1 (de) 2009-03-15

Family

ID=33560826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04774869T ATE423974T1 (de) 2003-08-12 2004-08-11 Verfahren zum nachweis geringer konzentrationen eines fusionsproteins

Country Status (11)

Country Link
US (1) US20060172345A1 (de)
EP (2) EP1507147A1 (de)
JP (1) JP2007502404A (de)
CN (1) CN1836165B (de)
AT (1) ATE423974T1 (de)
AU (1) AU2004264178A1 (de)
CA (1) CA2535073A1 (de)
DE (1) DE602004019659D1 (de)
DK (1) DK1660888T3 (de)
ES (1) ES2323067T3 (de)
WO (1) WO2005015235A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505509C (en) 2002-11-07 2013-08-20 Erasmus Universiteit Rotterdam Method and probes for the detection of a tumor specific fusion protein
EP2108956A1 (de) 2008-04-07 2009-10-14 Erasmus University Medical Center Rotterdam Verbesserte Verfahren und Kits zum Erkennen von tumorspezifischen Fusionsproteinen
NZ599460A (en) * 2009-10-20 2014-07-25 Nestec Sa Proximity-mediated assays for detecting oncogenic fusion proteins
KR102682118B1 (ko) 2016-04-29 2024-07-08 주식회사유한양행 Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091206A (en) * 1987-10-26 1992-02-25 Baxter Diagnostics Inc. Process for producing magnetically responsive polymer particles and application thereof
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
DE69332926T2 (de) * 1993-05-28 2004-03-11 Baxter International Inc., Deerfield Kontinuierliches zentrifugationsverfahren zum abtrennen von biologischen komponenten aus heterogenen zellpopulationen
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
US6107457A (en) * 1995-02-16 2000-08-22 Board Of Regents, The University Of Texas System Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US6686165B2 (en) * 1997-05-20 2004-02-03 Erasmus Universiteit Rotterdam Recognition of tumor-specific gene products in cancer
EP0983510B1 (de) * 1997-05-20 2004-03-03 Erasmus Universiteit Rotterdam Erkennung von tmorspezifische genprodukte
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
US7135340B2 (en) * 2001-11-07 2006-11-14 Stemcell Technologies Inc. Tetrameric antibody complexes for blocking non-specific labeling of antigens

Also Published As

Publication number Publication date
DE602004019659D1 (de) 2009-04-09
EP1660888B1 (de) 2009-02-25
DK1660888T3 (da) 2009-06-15
CN1836165B (zh) 2010-10-06
CA2535073A1 (en) 2005-02-17
EP1660888A1 (de) 2006-05-31
ES2323067T3 (es) 2009-07-06
EP1507147A1 (de) 2005-02-16
AU2004264178A1 (en) 2005-02-17
WO2005015235A1 (en) 2005-02-17
JP2007502404A (ja) 2007-02-08
CN1836165A (zh) 2006-09-20
US20060172345A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
ATE394680T1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
DE602004003842D1 (de) Verfahren und automatisiertes Microfluidsystem zum Nachweis von Proteinen in biologischen Proben
WO2004046164A3 (en) Unique recognition sequences and methods of use thereof in protein analysis
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
DE602006019111D1 (de) Verfahren zur isolierung von analyten aus einer probe
DE69918546D1 (de) Verfahren zur anregung eines optischen resonators zum nachweis von gasspuren
ATE410692T1 (de) Verfahren zur früherkennung der serokonversion eines gegen hepatitis c-virus gerichteten antikörpers
EP1477800A4 (de) Verfahren und vorrichtung zur aminosäure-, peptid-, protein-, saccharid- oder lipidanalyse
ATE326550T1 (de) Quantitative methode zum nachweis der nukleotidkonzentration
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE423974T1 (de) Verfahren zum nachweis geringer konzentrationen eines fusionsproteins
ATE225942T1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
DE602004003302D1 (de) Analytisches Verfahren und Vorrichtung zur Bestimmung der Metallkonzentration in flüssigen Kohlenwasserstoffen
DE69902796D1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
DE50105263D1 (de) Verfahren zur analyse von proteinen
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
DE60219429D1 (de) Biochemisches verfahren und vorrichtung zur bestimmung von eigenschaften von proteinen
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE10360844B4 (de) Verfahren zum Nachweis und zur Entfernung von Endotoxin
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen
DE60033190D1 (de) Verfahren zum nachweis von hepatitis c antigenen
ATE524737T1 (de) Verfahren und vorrichtung zur bestimmung mehrerer analyten mit simultaner internen kontrolle in einer grafischen kombination

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties